These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 21324801)
1. Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review. García-Sáenz JA; Custodio A; Casado A; Vidart JA; Coronado PJ; Martín M; López-Tarruella S; Puente J; Fernández C; Díaz-Rubio E Clin Transl Oncol; 2011 Feb; 13(2):121-32. PubMed ID: 21324801 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience. Bamias A; Karadimou A; Soupos N; Sotiropoulou M; Zagouri F; Haidopoulos D; Thomakos N; Rodolakis A; Antsaklis A; Dimopoulos MA Gynecol Oncol; 2011 Oct; 123(1):37-42. PubMed ID: 21764430 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review. Custodio Carretero AB; García Sáenz JA; González Larriba JL; Bobokova J; Calles Blanco A; Hernando Trancho F; García Paredes B; Rodríguez Lajusticia L; Díaz-Rubio García E Clin Transl Oncol; 2008 Sep; 10(9):560-71. PubMed ID: 18796373 [TBL] [Abstract][Full Text] [Related]
4. A systematic overview of chemotherapy effects in ovarian cancer. Högberg T; Glimelius B; Nygren P; Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma. Skírnisdóttir I; Lindborg K; Sorbe B Oncol Rep; 2007 Nov; 18(5):1249-56. PubMed ID: 17914581 [TBL] [Abstract][Full Text] [Related]
6. Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer. van der Burg ME; Onstenk W; Boere IA; Look M; Ottevanger PB; de Gooyer D; Kerkhofs LG; Valster FA; Ruit JB; van Reisen AG; Goey SH; van der Torren AM; ten Bokkel Huinink D; Kok TC; Verweij J; van Doorn HC Eur J Cancer; 2014 Oct; 50(15):2592-601. PubMed ID: 25096168 [TBL] [Abstract][Full Text] [Related]
7. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery. Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109 [TBL] [Abstract][Full Text] [Related]
8. Centralisation of epithelial ovarian cancer surgery: results on survival from a peripheral teaching hospital. van Vliet MM; Schreuder HW; Pasker-de Jong PC; Duk MJ Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():72-8. PubMed ID: 26177496 [TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study. van de Laar R; Zusterzeel PL; Van Gorp T; Buist MR; van Driel WJ; Gaarenstroom KN; Arts HJ; van Huisseling JC; Hermans RH; Pijnenborg JM; Schutter EM; Pelikan HM; Vollebergh JH; Engelen MJ; Inthout J; Kruitwagen RF; Massuger LF BMC Cancer; 2014 Jan; 14():22. PubMed ID: 24422892 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations. Jean S; Li J; Katsaros D; Wubbenhorst B; Maxwell KN; Fishbein L; McLane MW; Benedetto C; Canuto EM; Mitra N; Zhang L; Nathanson KL; Tanyi JL Oncotarget; 2016 Jul; 7(30):48577-48585. PubMed ID: 27191893 [TBL] [Abstract][Full Text] [Related]
11. Optimal treatment of early-stage ovarian cancer. Collinson F; Qian W; Fossati R; Lissoni A; Williams C; Parmar M; Ledermann J; Colombo N; Swart A; Ann Oncol; 2014 Jun; 25(6):1165-71. PubMed ID: 24631948 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness. da Costa Miranda V; de Souza Fêde ÂB; Dos Anjos CH; da Silva JR; Sanchez FB; da Silva Bessa LR; de Paula Carvalho J; Filho EA; de Freitas D; Del Pilar Estevez Diz M Gynecol Oncol; 2014 Feb; 132(2):287-91. PubMed ID: 24333355 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Winter-Roach BA; Kitchener HC; Lawrie TA Cochrane Database Syst Rev; 2012 Mar; 3(3):CD004706. PubMed ID: 22419298 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy. Cuylan ZF; Meydanli MM; Sari ME; Akbayir O; Celik H; Dede M; Sahin H; Gungorduk K; Kuscu E; Ozgul N; Gungor T; Ayhan A J Obstet Gynaecol Res; 2018 Jul; 44(7):1284-1293. PubMed ID: 29727055 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study. So KA; Hong JH; Jin HM; Kim JW; Song JY; Lee JK; Lee NW Gynecol Oncol; 2014 Mar; 132(3):551-5. PubMed ID: 24440470 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy and toxicity profile associated with intraperitoneal chemotherapy use in older women. Crim A; Rowland M; Ruskin R; Dvorak J; Greenwade M; Walter A; Gillen J; Ding K; Moore K; Gunderson C Gynecol Oncol; 2017 Aug; 146(2):268-272. PubMed ID: 28583323 [TBL] [Abstract][Full Text] [Related]
17. A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer. Krivak TC; Lele S; Richard S; Secord AA; Leath CA; Brower SL; Tian C; Moore RG Am J Obstet Gynecol; 2014 Jul; 211(1):68.e1-8. PubMed ID: 24530815 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. Maheshwari A; Kumar N; Gupta S; Rekhi B; Shylasree TS; Dusane R; Bajpai J; Ghosh J; Gulia S; Deodhar K; Menon S; Popat P; Sable N; Thakur M; Kerkar R Indian J Cancer; 2018; 55(1):50-54. PubMed ID: 30147093 [TBL] [Abstract][Full Text] [Related]
19. Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinoma. Chi DS; Waltzman RJ; Barakat RR; Spriggs DR Eur J Gynaecol Oncol; 1999; 20(4):277-80. PubMed ID: 10475122 [TBL] [Abstract][Full Text] [Related]
20. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group. Bamias A; Papadimitriou C; Efstathiou E; Rodolakis A; Vlahos G; Voulgaris Z; Bozas G; Fountzilas G; Aravantinos G; Razis E; Gika D; Dimopoulos MA BMC Cancer; 2006 Sep; 6():228. PubMed ID: 16999858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]